Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-05 6:33 pm |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
20,000 | $54.23 | $1,084,592 | 169,712 (Direct) |
View |
| 2025-02-10 Sale |
2025-02-12 7:55 pm |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
30,000 | $53.13 | $1,593,795 | 189,712 (Direct) |
View |
| 2024-12-03 Sale |
2024-12-05 6:14 pm |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
20,000 | $41.97 | $839,336 | 209,600 (Direct) |
View |
| 2024-09-03 Sale |
2024-09-04 4:05 pm |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
20,000 | $40.65 | $812,954 | 229,600 (Direct) |
View |
| 2024-06-03 Sale |
2024-06-05 4:07 pm |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
20,000 | $40.07 | $801,372 | 249,600 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-01 6:30 pm |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
32,000 | $85.35 | $2,731,088 | 301,541 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-26 4:31 pm |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
32,000 | $84.07 | $2,690,282 | 261,542 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-10 Option Award |
2025-01-14 4:32 pm |
N/A 2035-01-10 |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
105,983 | $0 | 298,672 (Direct) |
View |
| 2025-01-04 Tax Withholding |
2025-01-07 7:11 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
12,495 | $38.19 | 192,689 (Direct) |
View |
| 2025-01-06 Tax Withholding |
2025-01-07 7:11 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
4,416 | $38.86 | 192,689 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-12 7:23 pm |
2025-06-10 2034-06-10 |
Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director |
20,594 | $0 | 20,594 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-08 9:09 pm |
N/A 2034-01-03 |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
162,312 | $0 | 389,600 (Direct) |
View |
| 2024-01-05 Tax Withholding |
2024-01-08 9:09 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
4,469 | $37.96 | 389,600 (Direct) |
View |
| 2024-01-08 Tax Withholding |
2024-01-08 9:09 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
5,466 | $41.53 | 389,600 (Direct) |
View |
| 2023-06-12 Option Award |
2023-06-14 7:29 pm |
2024-06-12 2033-06-12 |
Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director |
22,123 | $0 | 22,123 (Direct) |
View |
| 2023-01-07 Tax Withholding |
2023-01-10 4:05 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
1,483 | $26.41 | 237,223 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:01 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
273,994 | $0 | 478,706 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:01 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
3,326 | $27.52 | 478,706 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 7:16 pm |
2023-06-08 2032-06-24 |
Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director |
42,087 | $0 | 42,087 (Direct) |
View |
| 2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
1,852 | $56.06 | 325,813 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-11 4:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
2,531 | $56.06 | 325,134 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:27 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
107,544 | $0 | 409,085 (Direct) |
View |
Ownership |
2021-03-25 9:36 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director |
0 | $0 | 135,561 (Direct) |
View |
Ownership |
2021-03-25 9:35 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director |
0 | $0 | 135,561 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:28 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
117,000 | $0 | 397,542 (Direct) |
View |